August 12, 2021

TFF Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update

August 5, 2021

TFF Pharmaceuticals to Present at the Investor Summit Virtual Conference on August 18, 2021

August 5, 2021

TFF Pharmaceuticals to Present at the SNN Virtual Investor Conference on August 19, 2021

August 4, 2021

TFF Pharmaceuticals to Hold Second Quarter 2021 Financial and Business Results Conference Call on August 12, 2021

July 29, 2021

Augmenta Bioworks and TFF Pharmaceuticals Announce Positive In Vitro Data Demonstrating Binding and Neutralization of the SARS-CoV-2 Delta Variant by Lead Anti-COVID-19 Antibody, AUG-3387

July 28, 2021

TFF Pharmaceuticals to Participate in the BTIG Virtual Biotechnology Conference

July 13, 2021

TFF Pharmaceuticals Announces Completion of Enrollment and Preliminary Data from its Phase 1 Clinical Trial of Tacrolimus Inhalation Powder

June 22, 2021

Augmenta Bioworks and TFF Pharmaceuticals Announce Selection of Lead Monoclonal Antibody Candidate AUG-3387 for Clinical Development Against COVID-19

June 7, 2021

TFF Pharmaceuticals Hosting Key Opinion Leader Perspectives on Thin Film Freezing Applications

May 25, 2021

TFF Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference